Inactive Instrument

HH&L Acquisition Co. Share Price

HHLA

KYG397141030

Latest news about HH&L Acquisition Co.

HH&L Acquisition Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20/11	CI
HH&L Acquisition Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
DiaCarta Inc. cancelled the acquisition of HH&L Acquisition Co. in a reverse merger transaction.	26/23/26	CI
HH&L Acquisition Co. announced that it expects to receive $3 million in funding	07/23/07	CI
HH&L Acquisition Co. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
HH&L Acquisition Co. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
HH&L Acquisition Co. Auditor Raises 'Going Concern' Doubt	31/23/31	CI
DiaCarta Gets FDA Authorization for Monkeypox Test Kit	12/23/12	DJ
HH&L Acquisition Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
HH&L Acquisition to Merge with DiaCarta	14/22/14	MT
DiaCarta Inc. agreed to acquire HH&L Acquisition Co. for approximately $460 million.	14/22/14	CI
HH&L Acquisition Co. announced that it expects to receive $0.5 million in funding from Hh&L Investment Co	15/22/15	CI
HH&L Acquisition Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI
HH&L Acquisition Co. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
HH&L Acquisition Co. Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI

More news

Press releases HH&L Acquisition Co.

Thinking about buying stock in FlexShopper, HH&L Acquisition, Vistagen Therapeutics, Vivos Therapeutics, or Missfresh?	08/23/08	PR
HH&L Acquisition : Merger Agreement - Form 8-K	02/23/02	PU
DiaCarta to Become a Publicly Listed Company Through Merger with HH&L Acquisition Co.	14/22/14	BU
HH&L Acquisition : Amendment to Quarterly Report (Form 10-Q/A)	20/21/20	PU

More press releases

Managers and Directors - HH&L Acquisition Co.

Managers	Title	Age	Since
Richard Qi Li CEO	Chief Executive Officer	54	-
Ying Jie Zhong DFI	Director of Finance/CFO	56	01/20/01
Hua Nan Yang COO	Chief Operating Officer	39	-

Members of the board	Title	Age	Since
Jingwu Zhang Zang BRD	Director/Board Member	68	04/21/04
Qing Jun Jin BRD	Director/Board Member	67	04/21/04
Richard Qi Li CEO	Chief Executive Officer	54	-

More insiders

ETFs positioned on HH&L Acquisition Co.

Name	Weight	AuM	1st Jan change	Investor Rating
CROSSINGBRIDGE PRE-MERGER SPAC ETF - USD	0.02%	66 M€	+1.54%	-

More ETFs positioned on HH&L Acquisition Co.

HH&L Acquisition Co is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to acquire one or more healthcare businesses, with a focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+137.37%	5.68B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.27%	819M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+21.31%	552M

Shell Companies